Casandra
Casandra Test Code QD71096Version 1 (DRAFT)
Performing Lab
ANCA Screen with MPO and PR3, with Reflex to ANCA Titer
Clinical Use
Order TestUse
Testing for anti–neutrophil cytoplasmic antibodies (P‑ANCA and/or C‑ANCA), including myeloperoxidase (MPO) and proteinase‑3 (PR3), is useful in establishing the diagnosis of suspected vascular diseases, inflammatory bowel disease, and other autoimmune disorders.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
5 targets
ANCA ScreenC‑ANCA TiterMyeloperoxidase AntibodyP‑ANCA (Atypical P‑ANCA) TiterProteinase‑3 Antibody
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2‑4 mL blood yielding serum
Minimum Volume
0.8 mL serum
Container
Red top (no additive) or Gold SST tube
Causes for Rejection
Gross hemolysis; grossly lipemic
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
Related Tests
Other tests from different labs that may be relevant
Myeloperoxidase (MPO) Antibody and Serine Proteinase 3 (PR3) Antibody with Reflex to Anti-Neutrophil Cytoplasmic Antibody, IgG by IFA
ARUP Laboratories
MPO/PR3 (ANCA) Antibodies
ARUP Laboratories
Antineutrophil Cytoplasmic Antibody (ANCA) Profile
Labcorp
ANCA-Associated Vasculitis Profile (ANCA/MPO/PR3)
ARUP Laboratories
Antineutrophil Cytoplasmic Antibodies Vasculitis Panel, Serum
Mayo Clinic Lab
Antimyeloperoxidase (MPO) Antibodies
Labcorp
Myeloperoxidase (MPO) Antibody
ARUP Laboratories
Antineutrophil Cytoplasmic Antibodies (ANCA)
Labcorp
Antiproteinase 3 (PR3) Antibodies
Labcorp
Anti-Neutrophil Cytoplasmic Ab (ANCA) by Indirect Immunofluorescence (IFA) (RDL)
Labcorp